Skip to main content
Clinical Trials/NCT03314233
NCT03314233
Completed
Not Applicable

Delayed Cord Clamping for Intubation and Gentle Ventilation in Infants With Congenital Diaphragmatic Hernia

Children's Hospital of Philadelphia1 site in 1 country21 target enrollmentOctober 12, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Diaphragmatic Hernia
Sponsor
Children's Hospital of Philadelphia
Enrollment
21
Locations
1
Primary Endpoint
Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Congenital diaphragmatic hernia (CDH) is a congenital anomaly associated with a high risk of mortality and need for life-saving interventions such as extracorporeal membrane oxygenation (ECMO), nitric oxide, and vasopressor support. Although infants with CDH experience significant morbidity and mortality starting immediately after birth, high quality evidence informing delivery room resuscitation in this population is lacking.

Infants with CDH are at risk for pulmonary hypoplasia and pulmonary hypertension and often experience hypoxemia and acidosis during neonatal transition. The standard approach to DR resuscitation is immediate umbilical cord clamping (UCC) followed by intubation and mechanical ventilation. Animal models suggest that achieving lung aeration prior to UCC results in improved pulmonary blood flow and cardiac function compared with immediate UCC before lung aeration is established. Trials of preterm infants demonstrated that initiating respiratory support prior to UCC is safe and feasible. Because infants with CDH are at high risk for pulmonary hypertension and systemic hypotension, they may benefit from the hemodynamic effects of lung aeration before UCC, namely increased pulmonary blood flow, decreased pulmonary vascular resistance, and improved cardiac output. To date, this approach has not been studied in infants with CDH.

Detailed Description

Congenital diaphragmatic hernia (CDH) is a congenital anomaly associated with a high risk of mortality (29%) and need for life-saving interventions such as ECMO (33%), nitric oxide (62%), and vasopressor support (73%).1 Although infants with CDH experience significant morbidity and mortality starting immediately after birth, high quality evidence informing delivery room resuscitation in this population is lacking. Infants with CDH are at risk for pulmonary hypoplasia and pulmonary hypertension and often experience hypoxemia and acidosis during neonatal transition. The standard approach to delivery room (DR) resuscitation is immediate UCC followed by intubation and mechanical ventilation. The goals of this strategy are to immediately recruit and aerate the lung for gas exchange and oxygenation, while simultaneously avoiding gaseous distention of the thoracic gastrointestinal contents. Animal models suggest that achieving lung aeration prior to UCC results in improved pulmonary blood flow and cardiac function compared with immediate UCC before lung aeration is established. Trials of preterm infants demonstrated that initiating respiratory support prior to UCC is safe and feasible. Because infants with CDH are at high risk for pulmonary hypertension and systemic hypotension, they may benefit from the hemodynamic effects of lung aeration before UCC, namely increased pulmonary blood flow, decreased pulmonary vascular resistance, and improved cardiac output. The investigators hypothesize that a sequence of intubation, gentle ventilation, and then umbilical cord clamping will result in improved cardiovascular transition after birth in infants with CDH. To date, this approach has not been studied in infants with CDH. The DING trial will assess the feasibility and safety of this intervention in infants with CDH.

Registry
clinicaltrials.gov
Start Date
October 12, 2017
End Date
October 9, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Antenatal diagnosis of CDH, with care in the Center for Fetal Treatment
  • Gestational age ≥ 36 weeks at birth

Exclusion Criteria

  • Multiple gestation
  • Major anomalies or aneuploidy
  • Enrolled in fetal endoluminal tracheal occlusion (FETO) trial
  • Palliative care planned or considered
  • Maternal diagnosis placenta previa, accreta, or abruption
  • Maternal diagnosis pre-eclampsia requiring Magnesium sulfate therapy at time of delivery
  • Obstetrics (OB) or Neonatal provider concerns for the clinical care of the mother or infant, or study team not available

Outcomes

Primary Outcomes

Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping

Time Frame: 3 minutes of life

Infants who are intubated and have ventilation initiated prior to umbilical cord clamping

Secondary Outcomes

  • Presence of Severe Pulmonary Hypertension(Approximately 24 hours of life)
  • Proportion of Infants Who Require Extracorporeal Membrane Oxygenation (ECMO) Treatment(7 days of life)
  • Mean Partial Pressure of O2 in Arterial Blood (PaO2)(Approximately 1 hour of life)
  • Mean Arterial Potential of Hydrogen (pH) in Arterial Blood(Approximately 1 hour of life)
  • Oxygenation Index (OI)(First obtained blood gas)
  • Proportion of Infants Who Require Vasopressors(First 48 hours of life)
  • Mortality in First 7 Days of Life(First 7 days of life)

Study Sites (1)

Loading locations...

Similar Trials